General Information of the Protein
Protein ID
PT02655
Protein Name
Mitogen-activated protein kinase 14
Secondarily
Protein Name
CRK1
Mitogen-activated protein kinase p38 alpha
Gene Name
MAPK14
Secondarily
Gene Name
Crk1
Csbp1
Csbp2
Sequence
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
    Show/Hide
Organism
Mus musculus, Mouse
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
CMGC protein kinase group
>
CMGC protein kinase MAPK family
>
CMGC protein kinase p38 subfamily
Function
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Phosphorylates S100A9 at 'Thr-113' (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
P47811

Secondarily ID:
B2KF37
B2KF38
O08666
Q3U6R5
Q3UZS3
Q8C289
Q9JLV8
Q9QZ80
    Show/Hide
Ensembl ID
ENSG00000112062
Subcellular Location
Cytoplasm
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000014 , RAW 264.7
Compound ID Compound Name Compound Formula
CP0661622
5-(2-tert-butyl-4-(2,4-difluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C25H31F2N5O3S
 1
1
IC50 = 20.7 nM
   TI
   LI
   LO
   TS
CP0670770
5-(2-(2,6-dichlorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C27H26Cl2FN5O3S
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0050755
6-[2-tert-Butyl-5-(2,4-difluoro-phenyl)-3H-imidazol-4-yl]-1-(propane-2-sulfonyl)-1H-benzoimidazol-2-ylamine; compound with methanesulfonic acid
   Show/Hide
C23H25F2N5O2S
 1
1
IC50 = 26.2 nM
   TI
   LI
   LO
   TS
CP0837940
6-(2-(2,6-dichlorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine monomesylate
   Show/Hide
C26H24Cl2FN5O5S2
 1
1
IC50 = 27.5 nM
   TI
   LI
   LO
   TS
CP0826616
5-(2-(2,6-dichlorophenyl)-4-(2,4-difluorophenyl)-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridine momomesylate
   Show/Hide
C26H23Cl2F2N5O3S
 1
1
IC50 = 31.2 nM
   TI
   LI
   LO
   TS
CP0655675
5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridine bismesylate
   Show/Hide
C25H32FN5O3S
 1
1
IC50 = 34.3 nM
   TI
   LI
   LO
   TS
CP0764458
5-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridin-2-amine monomesylate
   Show/Hide
C26H26F2N6O3S
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0744072
6-[2-(2,6-Dichloro-phenyl)-5-phenyl-3H-imidazol-4-yl]-1-(propane-2-sulfonyl)-1H-benzoimidazol-2-ylamine; compound with methanesulfonic acid
   Show/Hide
C26H25Cl2N5O5S2
 1
1
IC50 = 38.9 nM
   TI
   LI
   LO
   TS
CP0826710
5-(2-(2-chloro-6-fluorophenyl)-4-phenyl-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C27H27ClFN5O3S
 1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0728384
5-(2-tert-butyl-4-(2,4-difluorophenyl)-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C24H29F2N5O3S
 1
1
IC50 = 41.8 nM
   TI
   LI
   LO
   TS
CP0273641
6-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine
   Show/Hide
C25H21F2N5O2S
 1
1
IC50 = 45.7 nM
   TI
   LI
   LO
   TS
CP0727670
6-(4-(2,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine monomesylate
   Show/Hide
C21H23F2N5O5S2
 1
1
IC50 = 59.7 nM
   TI
   LI
   LO
   TS
CP0360161
6-(5-phenyl-2-pyridin-4-yl-1H-imidazol-4-yl)-1-propan-2-ylsulfonylbenzimidazol-2-amine
   Show/Hide
C24H22N6O2S
 1
1
IC50 = 62.3 nM
   TI
   LI
   LO
   TS
CP0785074
5-(2-(2,6-dichlorophenyl)-4-phenyl-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C26H25Cl2N5O3S
 1
1
IC50 = 64.7 nM
   TI
   LI
   LO
   TS
CP0807083
5-(2-tert-butyl-4-phenyl-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridine bismesylate
   Show/Hide
C24H31N5O3S
 1
1
IC50 = 66.4 nM
   TI
   LI
   LO
   TS
CP0728386
5-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-3-isobutyl-3H-imidazo[4,5-b]pyridine monomesylate
   Show/Hide
C26H25F2N5O3S
 1
1
IC50 = 69.7 nM
   TI
   LI
   LO
   TS
CP0799670
6-(2-(2-chloro-6-fluorophenyl)-4-phenyl-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine bismesylate
   Show/Hide
C26H25ClFN5O5S2
 1
1
IC50 = 74.5 nM
   TI
   LI
   LO
   TS
CP0716551
6-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-1-isobutyl-1H-benzo[d]imidazol-2-amine bismesylate
   Show/Hide
C27H27F2N5O3S
 1
1
IC50 = 78.3 nM
   TI
   LI
   LO
   TS
CP0777688
6-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-1-neopentyl-1H-benzo[d]imidazol-2-amine bismesylate
   Show/Hide
C28H29F2N5O3S
 1
1
IC50 = 126 nM
   TI
   LI
   LO
   TS
CP0255616
1-(isopropylsulfonyl)-6-(4-phenyl-1H-imidazol-5-yl)-1H-benzo[d]imidazol-2-amine
   Show/Hide
C19H19N5O2S
 1
1
IC50 = 195 nM
   TI
   LI
   LO
   TS
CP0728385
6-(4-(4-fluorophenyl)-2-methyl-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine monomesylate
   Show/Hide
C21H24FN5O5S2
 1
1
IC50 = 225 nM
   TI
   LI
   LO
   TS
CP0344125
6-[5-phenyl-2-[2-(trifluoromethyl)phenyl]-1H-imidazol-4-yl]-1-propan-2-ylsulfonylbenzimidazol-2-amine
   Show/Hide
C26H22F3N5O2S
 1
1
IC50 = 284 nM
   TI
   LI
   LO
   TS
CP0799671
5-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-3-(isopropylsulfonyl)-3H-imidazo[4,5-b]pyridin-2-amine monomesylate
   Show/Hide
C25H24F2N6O5S2
 1
1
IC50 = 298 nM
   TI
   LI
   LO
   TS
CP0307489
6-[2-(4-chlorophenyl)-5-phenyl-1H-imidazol-4-yl]-1-propan-2-ylsulfonylbenzimidazol-2-amine
   Show/Hide
C25H22ClN5O2S
 1
1
IC50 = 376 nM
   TI
   LI
   LO
   TS
CP0826618
6-(2-(2-chloro-6-(trifluoromethyl)phenyl)-4-phenyl-1H-imidazol-5-yl)-1-(isopropylsulfonyl)-1H-benzo[d]imidazol-2-amine monomesylate
   Show/Hide
C27H25ClF3N5O5S2
 1
1
IC50 = 398 nM
   TI
   LI
   LO
   TS
CP0785075
6-(2-(2,6-difluorophenyl)-4-phenyl-1H-imidazol-5-yl)-1H-benzo[d]imidazole bismesylate
   Show/Hide
C23H18F2N4O3S
 1
1
IC50 = 766 nM
   TI
   LI
   LO
   TS